Cellectar Biosciences Inc (CLRB.OQ)
CLRB.OQ on NASDAQ Stock Exchange Capital Market
2.18USD
21 Aug 2019
2.18USD
21 Aug 2019
Change (% chg)
-- (--)
-- (--)
Prev Close
$2.18
$2.18
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
72,898
72,898
52-wk High
$4.25
$4.25
52-wk Low
$1.22
$1.22
About
Cellectar Biosciences, Inc., formerly Novelos Therapeutics, Inc., is a clinical stage biopharmaceutical company. The Company is engaged in developing phospholipid ether-drug conjugates (PDCs) for the treatment and diagnostic imaging of cancer. Its research and development program is based on its PDC cancer targeting delivery... (more)
Overall
| Beta: | 1.16 |
| Market Cap(Mil.): | $11.55 |
| Shares Outstanding(Mil.): | 5.40 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CLRB.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 29.73 | 33.85 |
| EPS (TTM): | -4.83 | -- | -- |
| ROI: | -150.37 | 13.04 | 12.69 |
| ROE: | -210.13 | 14.12 | 17.13 |
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.✕
Estimates